This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Naiyer A Rizvi: Innovator in Cancer Immunotherapy
Introduction
Naiyer A Rizvi is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly in the area of immunotherapy. His work focuses on understanding the molecular determinants that influence cancer response to treatment.
Latest Patents
Naiyer A Rizvi holds a patent titled "Determinants of cancer response to immunotherapy by PD-1 blockade." This patent describes the molecular determinants of cancer response to immunotherapy and outlines systems and tools for identifying and characterizing cancers that are likely to respond to such treatments. He has 1 patent to his name.
Career Highlights
Naiyer A Rizvi is affiliated with the Memorial Sloan Kettering Cancer Center, where he conducts groundbreaking research. His work has been instrumental in advancing the understanding of how certain cancers respond to immunotherapy, paving the way for more effective treatment options.
Collaborations
He collaborates with esteemed colleagues, including Timothy A Chan and Matthew D Hellmann, to further enhance the impact of his research in the field of cancer immunotherapy.
Conclusion
Naiyer A Rizvi is a key figure in cancer research, with a focus on immunotherapy and its molecular determinants. His innovative work continues to contribute to the advancement of cancer treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile